Still incredibly cheap. Can double with no further news and I wouldn't bat an eyelid on the valuation. As per thread above - Has the right mix of factors. Really believe this can go all the way.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025